Miller, R.A. & Birnbaum, M.J. Glucagon: acute actions on hepatic metabolism. Diabetologia 59, 1376–1381 (2016).
Scott, R.A. et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat. Genet. 44, 991–1005 (2012).
Suhre, K. et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 477, 54–60 (2011).
Exton, J.H. & Park, C.R. Control of gluconeogenesis in liver. II. Effects of glucagon, catecholamines, and adenosine 3′,5′-monophosphate on gluconeogenesis in the perfused rat liver. J. Biol. Chem. 243, 4189–4196 (1968).
Young, V.R. & Ajami, A.M. Glutamine: the emperor or his clothes? J. Nutr. 131, 2449S–2459S discussion 2486S–2447S (2001).
Miller, R.A. et al. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature 494, 256–260 (2013).
Titchenell, P.M. et al. Direct hepatocyte insulin signaling is required for lipogenesis but is dispensable for the suppression of glucose production. Cell Metab. 23, 1154–1166 (2016).
Williamson, J.R. et al. Mechanisms involved in receptor-mediated changes of intracellular Ca2+ in liver. Soc. Gen. Physiol. Ser. 42, 93–116 (1987).
Watford, M. & Smith, E.M. Distribution of hepatic glutaminase activity and mRNA in perivenous and periportal rat hepatocytes. Biochem. J. 267, 265–267 (1990).
Hu, W. et al. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc. Natl. Acad. Sci. USA 107, 7455–7460 (2010).
Suzuki, S. et al. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc. Natl. Acad. Sci. USA 107, 7461–7466 (2010).
Krishna, M.G. et al. Glucagon response to exercise is critical for accelerated hepatic glutamine metabolism and nitrogen disposal. Am. J. Physiol. Endocrinol. Metab. 279, E638–E645 (2000).
Stumvoll, M., Meyer, C., Kreider, M., Perriello, G. & Gerich, J. Effects of glucagon on renal and hepatic glutamine gluconeogenesis in normal postabsorptive humans. Metabolism 47, 1227–1232 (1998).
Battezzati, A., Simonson, D.C., Luzi, L. & Matthews, D.E. Glucagon increases glutamine uptake without affecting glutamine release in humans. Metabolism 47, 713–723 (1998).
Hankard, R.G., Haymond, M.W. & Darmaun, D. Role of glutamine as a glucose precursor in fasting humans. Diabetes 46, 1535–1541 (1997).
Stumvoll, M. et al. Glutamine and alanine metabolism in NIDDM. Diabetes 45, 863–868 (1996).
Perriello, G. et al. Estimation of gluco
se–alanine–lactate–glutamine cycles in postabsorptive humans: role of skeletal muscle. Am. J. Physiol. 269, E443–E450 (1995).
Nurjhan, N. et al. Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man. J. Clin. Invest. 95, 272–277 (1995).
Halestrap, A.P. Stimulation of the respiratory chain of rat liver mitochondria between cytochrome c1 and cytochrome c by glucagon treatment of rats. Biochem. J. 172, 399–405 (1978).
Yamazaki, R.K. Glucagon stimulation of mitochondrial respiration. J. Biol. Chem. 250, 7924–7930 (1975).
Stumvoll, M., Perriello, G., Meyer, C. & Gerich, J. Role of glutamine in human carbohydrate metabolism in kidney and other tissues. Kidney Int. 55, 778–792 (1999).
Mauger, J.P., Claret, M., Pietri, F. & Hilly, M. Hormonal regulation of inositol 1,4,5-trisphosphate receptor in rat liver. J. Biol. Chem. 264, 8821–8826 (1989).
Burgess, G.M., Bird, G.S., Obie, J.F. & Putney, J.W. Jr. The mechanism for synergism between phospholipase C– and adenylylcyclase-linked hormones in liver. Cyclic AMP–dependent kinase augments inositol trisphosphate–mediated Ca2+ mobilization without increasing the cellular levels of inositol polyphosphates. J. Biol. Chem. 266, 4772–4781 (1991).
Bygrave, F.L., Gamberucci, A., Fulceri, R. & Benedetti, A. Evidence that stimulation of plasma-membrane Ca2+ inflow is an early action of glucagon and dibutyryl cyclic AMP in rat hepatocytes. Biochem. J. 292, 19–22 (1993).
Fernando, K.C., Gregory, R.B. & Barritt, G.J. Protein kinase A regulates the disposition of Ca2+ which enters the cytoplasmic space through store-activated Ca2+ channels in rat hepatocytes by diverting inflowing Ca2+ to mitochondria. Biochem. J. 330, 1179–1187 (1998).
Hughes, B.P. & Barritt, G.J. Effects of glucagon and N6O2′-dibutyryladenosine 3′:5′-cyclic monophosphate on calcium transport in isolated rat liver mitochondria. Biochem. J. 176, 295–304 (1978).
Keppens, S., Vandenheede, J.R. & De Wulf, H. On the role of calcium as second messenger in liver for the hormonally induced activation of glycogen phosphorylase. Biochim. Biophys. Acta 496, 448–457 (1977).
Denton, R.M. & McCormack, J.G. Ca2+ transport by mammalian mitochondria and its role in hormone action. Am. J. Physiol. 249, E543–E554 (1985).
Siess, E.A. & Wieland, O.H. Glucagon-induced stimulation of 2-oxoglutarate metabolism in mitochondria from rat liver. FEBS Lett. 93, 301–306 (1978).
Williamson, J.R., Browning, E.T., Thurman, R.G. & Scholz, R. Inhibition of glucagon effects in perfused rat liver by (+)decanoylcarnitine. J. Biol. Chem. 244, 5055–5064 (1969).
Lacey, J.H., Bradford, N.M., Joseph, S.K. & McGivan, J.D. Increased activity of phosphate-dependent glutaminase in liver mitochondria as a result of glucagon treatment of rats. Biochem. J. 194, 29–33 (1981).
Joseph, S.K. & McGivan, J.D. The effect of ammonium chloride and glu
cagon on the metabolism of glutamine in isolated liver cells from starved rats. Biochim. Biophys. Acta 543, 16–28 (1978).
Low, S.Y., Salter, M., Knowles, R.G., Pogson, C.I. & Rennie, M.J. A quantitative analysis of the control of glutamine catabolism in rat liver cells. Use of selective inhibitors. Biochem. J. 295 (Pt. 2), 617–624 (1993).
Lu, W. et al. Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer. Anal. Chem. 82, 3212–3221 (2010).
Melamud, E., Vastag, L. & Rabinowitz, J.D. Metabolomic analysis and visualization engine for LC–MS data. Anal. Chem. 82, 9818–9826 (2010).
Weitzel, M. et al. 13CFLUX2 – high-performance software suite for 13C-metabolic flux analysis. Bioinformatics 29, 143–145 (2013).
Wiechert, W., Mollney, M., Isermann, N., Wurzel, M. & de Graaf, A.A. Bidirectional reaction steps in metabolic networks: III. Explicit solution and analysis of isotopomer labeling systems. Biotechnol. Bioeng. 66, 69–85 (1999).
Antoniewicz, M.R., Kelleher, J.K. & Stephanopoulos, G. Determination of confidence intervals of metabolic fluxes estimated from stable isotope measurements. Metab. Eng. 8, 324–337 (2006).